Literature DB >> 19418582

Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation.

Barbara Renga1, Andrea Mencarelli, Marco Migliorati, Eleonora Distrutti, Stefano Fiorucci.   

Abstract

AIM: To investigate whether the farnesoid X receptor (FXR) regulates expression of liver cystathionase (CSE), a gene involved in hydrogen sulfide (H(2)S) generation.
METHODS: The regulation of CSE expression in response to FXR ligands was evaluated in HepG2 cells and in wild-type and FXR null mice treated with 6-ethyl chenodeoxycholic acid (6E-CDCA), a synthetic FXR ligand. The analysis demonstrated an FXR responsive element in the 5'-flanking region of the human CSE gene. The function of this site was investigated by luciferase reporter assays, chromatin immunoprecipitation and electrophoretic mobility shift assays. Livers obtained from rats treated with carbon tetrachloride alone, or in combination with 6-ethyl chenodeoxycholic acid, were studied for hydrogen sulphide generation and portal pressure measurement.
RESULTS: Liver expression of CSE is regulated by bile acids by means of an FXR-mediated mechanism. Western blotting, qualitative and quantitative polymerase chain reaction, as well as immunohistochemical analysis, showed that expression of CSE in HepG2 cells and in mice is induced by treatment with an FXR ligand. Administration of 6E-CDCA to carbon tetrachloride treated rats protected against the down-regulation of CSE expression, increased H(2)S generation, reduced portal pressure and attenuated the endothelial dysfunction of isolated and perfused cirrhotic rat livers.
CONCLUSION: These results demonstrate that CSE is an FXR-regulated gene and provide a new molecular explanation for the pathophysiology of portal hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19418582      PMCID: PMC2678580          DOI: 10.3748/wjg.15.2097

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Enzymatic assay of gamma-cystathionase activity using pyruvate oxidase-peroxidase sequential reaction.

Authors:  Yuki Ogasawara; Kazuyuki Ishii; Shinzo Tanabe
Journal:  J Biochem Biophys Methods       Date:  2002-04-18

2.  NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension.

Authors:  S Fiorucci; E Antonelli; O Morelli; A Mencarelli; A Casini; T Mello; B Palazzetti; D Tallet; P del Soldato; A Morelli
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

3.  The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener.

Authors:  W Zhao; J Zhang; Y Lu; R Wang
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

Review 4.  BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis.

Authors:  Peter A Edwards; Heidi R Kast; Andrew M Anisfeld
Journal:  J Lipid Res       Date:  2002-01       Impact factor: 5.922

5.  Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

Authors:  C J Sinal; M Tohkin; M Miyata; J M Ward; G Lambert; F J Gonzalez
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

Review 6.  Nitric oxide and portal hypertension.

Authors:  Juan González-Abraldes; Juan Carlos García-Pagán; Jaime Bosch
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

7.  Effect of acute betaine administration on hepatic metabolism of S-amino acids in rats and mice.

Authors:  Sang K Kim; Kwon H Choi; Young C Kim
Journal:  Biochem Pharmacol       Date:  2003-05-01       Impact factor: 5.858

8.  The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility.

Authors:  B Teague; S Asiedu; P K Moore
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

9.  The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase.

Authors:  GuangZhen Zhong; FengRong Chen; YouQin Cheng; ChaoShu Tang; JunBao Du
Journal:  J Hypertens       Date:  2003-10       Impact factor: 4.844

10.  Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine.

Authors:  Shigeru Murakami; Yukiko Kondo; Yoshihisa Toda; Hideaki Kitajima; Kazuya Kameo; Masanobu Sakono; Nobuhiro Fukuda
Journal:  Life Sci       Date:  2002-04-05       Impact factor: 5.037

View more
  14 in total

1.  Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice.

Authors:  Stefano Fiorucci; Andrea Mencarelli; Sabrina Cipriani; Barbara Renga; Giuseppe Palladino; Luca Santucci; Eleonora Distrutti
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

2.  Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice.

Authors:  Hiroyuki Tsuchiya; Kerry-Ann da Costa; Sangmin Lee; Barbara Renga; Hartmut Jaeschke; Zhihong Yang; Stephen J Orena; Michael J Goedken; Yuxia Zhang; Bo Kong; Margitta Lebofsky; Swetha Rudraiah; Rana Smalling; Grace Guo; Stefano Fiorucci; Steven H Zeisel; Li Wang
Journal:  Gastroenterology       Date:  2015-02-19       Impact factor: 22.682

Review 3.  Regulators of the transsulfuration pathway.

Authors:  Juan I Sbodio; Solomon H Snyder; Bindu D Paul
Journal:  Br J Pharmacol       Date:  2018-08-23       Impact factor: 8.739

Review 4.  Hydrogen sulfide signaling in mitochondria and disease.

Authors:  Brennah Murphy; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  FASEB J       Date:  2019-10-24       Impact factor: 5.834

5.  Novel treatment options for portal hypertension.

Authors:  Philipp Schwabl; Wim Laleman
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-04-18

6.  Impact of hyperglycemia on cystathionine-γ-lyase expression during resuscitated murine septic shock.

Authors:  Tamara Merz; Josef A Vogt; Ulrich Wachter; Enrico Calzia; Csaba Szabo; Rui Wang; Peter Radermacher; Oscar McCook
Journal:  Intensive Care Med Exp       Date:  2017-06-14

Review 7.  Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia.

Authors:  Eelke M Bos; Harry van Goor; Jaap A Joles; Matthew Whiteman; Henri G D Leuvenink
Journal:  Br J Pharmacol       Date:  2015-03       Impact factor: 8.739

8.  HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes.

Authors:  Barbara Renga; Daniela Francisci; Claudio D'Amore; Elisabetta Schiaroli; Adriana Carino; Franco Baldelli; Stefano Fiorucci
Journal:  BMC Infect Dis       Date:  2012-10-29       Impact factor: 3.090

Review 9.  FXR an emerging therapeutic target for the treatment of atherosclerosis.

Authors:  Andrea Mencarelli; Stefano Fiorucci
Journal:  J Cell Mol Med       Date:  2010-01       Impact factor: 5.310

10.  Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1.

Authors:  Barbara Renga; Sabrina Cipriani; Adriana Carino; Michele Simonetti; Angela Zampella; Stefano Fiorucci
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.